World's Best Scientists 2026 revealed!
Giorgio Ciprandi

Giorgio Ciprandi

D-Index & Metrics

Immunology

D-Index
78
Citations
29681
World Ranking
1723
National Ranking
66

Medicine

D-Index
78
Citations
29849
World Ranking
17859
National Ranking
720

Giorgio Ciprandi publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Giorgio Ciprandi sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 892 publications — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Giorgio Ciprandi D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Giorgio Ciprandi sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 78 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Giorgio Ciprandi is affiliated with the University of Genoa in Italy and has an extensive publication record in the field of Medicine, with a total of 651 publications. Their research spans several subfields, including Physiology, Immunology and Allergy, Pulmonary and Respiratory Medicine, Emergency Medical Services, and Surgery.

The scientist has contributed to multiple topical areas in health research, especially focusing on:

  • Asthma and respiratory diseases
  • Allergic Rhinitis and Sensitization
  • Respiratory and Cough-Related Research
  • Pediatric health and respiratory diseases
  • Sinusitis and nasal conditions
  • Food Allergy and Anaphylaxis Research
  • Olfactory and Sensory Function Studies

Giorgio Ciprandi's recent papers demonstrate involvement in pediatric and respiratory health as well as allergy-related studies. Selected publications include:

  • The psycho-social effects of COVID-19 on Italian adolescents' attitudes and behaviors (2020), published in The Italian Journal of Pediatrics
  • Defying hard-to-heal wounds with an early antibiofilm intervention strategy: wound hygiene (2020), Journal of Wound Care
  • Impact that the COVID-19 pandemic on routine childhood vaccinations and challenges ahead: A narrative review (2021), Acta Paediatrica
  • Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic (2020), The Italian Journal of Pediatrics
  • Characterization of T2-Low and T2-High Asthma Phenotypes in Real-Life (2021), Biomedicines

The scientist regularly publishes in several venues, with a frequent presence in:

  • PubMed
  • Journal of Biological Regulators and Homeostatic Agents
  • Minerva Pediatrics
  • Allergologia et Immunopathologia
  • Gazzetta Medica Italiana Archivio per le Scienze Mediche

Collaborations with other researchers are a part of Giorgio Ciprandi's work, including frequent co-authors such as Gian Luigi Marseglia, Amelia Licari, Maria Angela Tosca, and Michele Miraglia del Giudice.

Best Publications

  • Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

    J. Bousquet;H. J. Schünemann;B. Samolinski;P. Demoly

  • International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

    Sarah K. Wise;Sandra Y. Lin;Elina Toskala;Richard R. Orlandi

  • Antiallergic drugs and the immune response. Interactions and possible clinical relevance.

    G. W. Canonica;G. Ciprandi

  • Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy

    Giorgio Ciprandi;Sandra Buscaglia;Giampaola Pesce;Caterina Pronzato

  • MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

    J. Bousquet;H. J. Schunemann;J. Fonseca;B. Samolinski

  • The nose-lung interaction in allergic rhinitis and asthma: united airways disease.

    Giovanni Passalacqua;Giorgio Ciprandi;Giorgio Walter Canonica

  • The safety of sublingual-swallow immunotherapy: an analysis of published studies.

    G. B. Gidaro;F. Marcucci;L. Sensi;C. Incorvaia

  • ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

    J Bousquet;P W Hellings;I Agache;A Bedbrook

  • Serum interleukin-17 levels are related to clinical severity in allergic rhinitis

    G Ciprandi;M De Amici;G Murdaca;D Fenoglio

  • Seasonal and perennial allergic rhinitis: is this classification adherent to real life?

    G. Ciprandi;I. Cirillo;A. Vizzaccaro;M. Tosca

  • Types of sensitization to aeroallergens: definitions, prevalences and impact on the diagnosis and treatment of allergic respiratory disease

    Michel Migueres;Ignacio Dávila;Franco Frati;Angel Azpeitia

  • Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement

    Peter Hellings;Peter Hellings;W J Fokkens;C Bachert;C Bachert;C A Akdis

  • United airways disease: therapeutic aspects

    Giovanni Passalacqua;Giorgio Ciprandi;Giorgio Walter Canonica

  • Asthma Endotyping and Biomarkers in Childhood Asthma.

    Amelia Licari;Riccardo Castagnoli;Ilaria Brambilla;Alessia Marseglia

  • Minimal persistent inflammation is also present in patients with seasonal allergic rhinitis

    Vittorio Ricca;Massimo Landi;Paola Ferrero;Alessandra Bairo

  • The psycho-social effects of COVID-19 on Italian adolescents' attitudes and behaviors.

    Carlo Buzzi;Maurizio Tucci;Riccardo Ciprandi;Ilaria Brambilla

  • Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

    Jean Bousquet;Jean Bousquet;Peter W. Hellings;Ioana Agache;Flore Amat

  • Allergen-specific challenge induces intercellular adhesion molecule 1 (ICAM-1 or CD54) on nasal epithelial cells in allergic subjects. Relationships with early and late inflammatory phenomena.

    G Ciprandi;C Pronzato;V Ricca;G Passalacqua

  • The impact of anxiety and depression on outpatients with asthma.

    Giorgio Ciprandi;Irene Schiavetti;Elena Rindone;Fabio L.M. Ricciardolo

  • Allergic children have more numerous and severe respiratory infections than non-allergic children.

    Giorgio Ciprandi;Maria Angela Tosca;Lilia Fasce

  • Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge

    Giorgio Ciprandi;Sandra Buscaglia;Giampaola Pesce;Giovanni Passalacqua

Frequent Co-Authors

Giorgio Walter Canonica
Giorgio Walter Canonica Humanitas University
Amelia Licari
Amelia Licari University of Pavia
Angela Pistorio
Angela Pistorio Istituto Giannina Gaslini
Catherine Klersy
Catherine Klersy University of Pavia
Giovanni Passalacqua
Giovanni Passalacqua University of Genoa
Giuseppe Murdaca
Giuseppe Murdaca University of Genoa
Pascal Demoly
Pascal Demoly University of Montpellier
Inger Kull
Inger Kull Karolinska Institute
Alessandro Fiocchi
Alessandro Fiocchi Bambino Gesù Children's Hospital
Jean Bousquet
Jean Bousquet University of Montpellier

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA often opens doors to diverse healthcare careers, including advanced nursing roles. For those with a nursing background looking to enhance their credentials, exploring accelerated NP programs online can be an efficient way to transition into specialized fields.

Nurses interested in critical care can pursue an acute care nurse practitioner certification, which prepares them to manage complex patient needs in hospital settings. This certification complements immunology knowledge by offering practical skills for treating immunocompromised patients.

For those beginning their nursing journey without prior experience, enrolling in online accelerated nursing programs for non nurses provides a fast-tracked path to enter the healthcare workforce. These programs can serve as a foundation for further specialization in immunology or related fields.

It's also important to consider earnings potential when planning a career. Understanding how much does a dnp make can help prospective students and professionals make informed decisions about their education and career pathways in healthcare.

Best Scientists Citing Giorgio Ciprandi

Trending Scientists

Recently Published Articles